GSK to partner with venture capital firm for drug discovery
(Reuters) - GlaxoSmithKline said on Monday it will partner with venture capitalists Avalon Ventures in a deal worth up to $495 million to fund as many...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/zxGTmANlAj8/story01.htm
No comments:
Post a Comment